Neuroprotection of S-nitrosoglutathione against ischemic injury by down-regulating Fas S-nitrosylation and downstream signaling

Neuroscience

Volumn 248, Issue , 2013, Pages 290-298

  Yin, X H ^a,b   Yan, J Z ^b   Hou, X Y ^b   Wu, S L ^a   Zhang, G Y ^b  

^a SOOCHOW UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Fas; Neuronal nitric oxide synthase; S nitrosoglutathione; S nitrosylation

Indexed keywords

7 NITROINDAZOLE; CASPASE 3; CASPASE 8; CASPASE 9; FAS ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN BID; S NITROSOGLUTATHIONE; 7-NITROINDAZOLE; FAS LIGAND; INDAZOLE DERIVATIVE; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; HIPPOCAMPAL CA1 REGION; INTERNALIZATION; MALE; NEUROPROTECTION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN SECRETION; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NERVE CELL; PROTEIN PROCESSING; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, CD95; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; CASPASE 3; CASPASE 8; CASPASE 9; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FAS LIGAND PROTEIN; INDAZOLES; MALE; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE I; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; S-NITROSOGLUTATHIONE; SIGNAL TRANSDUCTION;

EID: 84880422190     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.06.012     Document Type: Article

References (39)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 2002, 298(5594):846-850.
2. Andoh T., Lee S.Y., Chiueh C.C. Preconditioning regulation of bcl-2 and p66shc by human NOS1 enhances tolerance to oxidative stress. FASEB J 2000, 14(14):2144-2146.
3. Boldin M.P., Varfolomeev E.E., Pancer Z., Mett I.L., Camonis J.H., Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995, 270:7795-7798.
4. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 1996, 85:803-815.
5. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505-512.
6. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 1999, 274(39):27467-27473.
7. Di J.H., Li C., Yu H.M., Zheng J.N., Zhang G.Y. NNOS downregulation attenuates neuronal apoptosis by inhibiting nNOS-GluR6 interaction and GluR6 nitrosylation in cerebral ischemic reperfusion. Biochem Biophys Res Commun 2012, 420(3):594-599.
8. Eliasson M.J., Huang Z., Ferrante R.J., Sasamata M., Molliver M.E., Snyder S.H., Moskowitz M.A. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci 1999, 19:5910-5918.
9. Feig C., Tchikov V., Schütze S., Peter M.E. Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J 2007, 26(1):221-231.
10. Foster M.W., Hess D.T., Stamler J.S. Protein S-nitrosylation in health and disease: a current perspective. Cell 2009, 15:391-404.
11. Hu S.Q., Ye J.S., Zong Y.Y., Sun C.C., Liu D.H., Wu Y.P., Song T., Zhang G.Y. S-Nitrosylation of mixed lineage kinase 3 contributes to its activation after cerebral ischemia. J Biol Chem 2012, 287(4):2364-2377.
12. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schröter M., Burns K., Mattmann C., Rimoldi D., French L.E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-194.
13. Ishikawa A., Kubota Y., Murayama T., Nomura Y. Cell death by 1-chloro-2,4-dinitrobenzene, an inhibitor of thioredoxin reductase and its dual regulation by nitric oxide in rats. Neurosci Lett 1999, 277(2):99-102.
14. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 2001, 3(2):193-197.
15. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., Peter M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (Dros. Inf. Serv.C) with the receptor. EMBO J 1995, 14:5579-5588.
16. Krammer P.H. CD95's deadly mission in the immune system. Nature 2000, 407:789-795.
17. Leon-Bollotte L., Subramaniam S., Cauvard O., Plenchette-Colas S., Paul C., Godard C., Martinez-Ruiz A., Legembre P., Jeannin J.F., Bettaieb A. S-nitrosylation of the death receptor Fas promotes Fas ligand-mediated apoptosis in cancer cells. Gastroenterology 2011, 140(7):2009-2018.
18. Liu X.M., Pei D.S., Guan Q.H., Sun Y.F., Wang X.T., Zhang Q.X., Zhang G.Y. Neuroprotection of Tat-GluR6-9c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear pathways. J Biol Chem 2006, 281(25):17432-17445.
19. Liu L., Kim J.Y., Koike M.A., Yoon Y.J., Tang X.N., Ma H., Lee H., Steinberg G.K., Lee J.E., Yenari M.A. FasL shedding is reduced by hypothermia in experimental stroke. J Neurochem 2008, 106(2):541-550.
20. Liu D.H., Yuan F.G., Hu S.Q., Diao F., Wu Y.P., Zong Y.Y., Song T., Li C., Zhang G.Y. Endogenous nitric oxide induces activation of apoptosis signal-regulating kinase 1 via S-nitrosylation in rat hippocampus during cerebral ischemia-reperfusion. Neuroscience 2012, 229:36-48.
21. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T., Debatin K.M. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999, 19:3809-3817.
22. Martin-Villalba A., Hahne M., Kleber S., Vogel J., Falk W., Schenkel J., Krammer P.H. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 2001, 8:679-686.
23. Mehmet H. Stroke treatment enters the Fas lane. Cell Death Differ 2001, 8:659-661.
24. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 1996, 85:817-827.
25. Nagata S. Apoptosis by death factor. Cell 1997, 88:355-365.
26. Pan H.P., Li G. Protecting mechanism of puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemia-reperfusion injury. Yakugaku Zassh 2008, 128(11):1689-1698.
27. Pei D.S., Wang X.T., Liu Y., Sun Y.F., Guan Q.H., Wang W., Yan J.Z., Zong Y.Y., Xu T.L., Zhang G.Y. Neuroprotection against ischemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence. Brain 2006, 129:465-479.
28. Pulsinelli W.A., Brierley J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979, 10:267-272.
29. Qi S.H., Hao L.Y., Yue J., Zong Y.Y., Zhang G.Y. Exogenous nitric oxide negatively regulates the s-nitrosylation p38 mitogen-activated protein kinase activation during cerebral ischaemia and reperfusion. Neuropathol Appl Neurobiol 2012, 9(3):284-297.
30. Qu Z.W., Miao W.Y., Hu S.Q., Li C., Zhuo X.L., Zong Y.Y., Wu Y.P., Zhang G.Y. N-methyl-d-aspartate receptor-dependent denitrosylation of neuronal nitric oxide synthase increase the enzyme activity. PLoS One 2012, 7(12):e52788.
31. Reich A., Spering C., Gertz K., Harms C., Gerhardt E., Kronenberg G., Nave K.A., Schwab M., Tauber S.C., Drinkut A., Harms K., Beier C.P., Voigt A., Göbbels S., Endres M., Schulz J.B. Fas/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia. J Neurosci 2011, 31(1):225-233.
32. Rosenbaum D.M., Gupta G., D'Amore J., Singh M., Weidenheim K., Zhang H., Kessler J.A. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J Neurosci 2000, 61:686-692.
33. Ruan W., Lee C.T., Desbarats J. A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates rac1 and controls neurite growth. Mol Biol Cell 2008, 19(8):3192-3202.
34. Stamler J.S., Toone E.J., Lipton S.A., Sucher N.J. NO signals: Translocation, regulation, and a consensus motif. Neuron 1997, 18:691-696.
35. Straus S.E., Jaffe E.S., Puck J.M., Dale J.K., Elkon K.B., Rosen-Wolff A., Peters A.M., Sneller M.C., Hallahan C.W., Wang J., Fischer R.E., Jackson C.M., Lin A.Y., Bäumler C., Siegert E., Marx A., Vaishnaw A.K., Grodzicky T., Fleisher T.A., Lenardo M.J. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001, 98:194-200.
36. Wang Y.R., Liu R.Y., Wang L.C., Mao H.F., Chen J.Q. Effect of Huwentoxin-I on the Fas and TNF apoptosis pathway in the hippocampus of rat with global cerebral ischemia. Toxicon 2007, 50(8):1085-1094.
37. Yang Z.J., Carter E.L., Torbey M.T., Martin L.J., Koehler R.C. Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons. Exp Neurol 2010, 221(1):166-174.
38. Yun H.Y., Gonzalez-Zulueta M., Dawson V.L., Dawson T.M. Nitric oxide mediates N-methyl-d-aspartate receptor induced activation of p21ras. Proc Natl Acad Sci U S A 1998, 95:5773-5778.
39. Zhang J., Yan H., Wu Y.P., Li C., Zhang G.Y. Activation of GluR6-containing kainate receptors induces ubiquitin-dependent Bcl-2 degradation via denitrosylation in the rat hippocampus after kainate treatment. J Biol Chem 2011, 286(9):7669-7680.